Ballarin RS et al., 2024-04-18: Meta-analysis of three RCTs (141 patients) in sepsis and septic shock finding shorter vasopressor duration, ICU stay and ventilation with methylene blue.
Administering methylene blue to patients with sepsis and septic shock leads to reduced time to vasopressor discontinuation, length of intensive care unit stay, and days on mechanical ventilation.
Ballarin RS et al., 2024-04-18: Meta-analysis of three RCTs (141 patients) in sepsis and septic shock finding shorter vasopressor duration, ICU stay and ventilation with methylene blue. C5. Study type: systematic review and meta-analysis of placebo-controlled RCTs, 3 studies, N=141 (70 MB, 71 control); Sao Paulo State University (UNESP), Brazil. PROSPERO CRD42023423470. Reported effects: ICU LOS MD -1.58 days, ventilation MD -0.72 days, time to vasopressor discontinuation MD -31.49 hours; no association with methemoglobinemia. Dose not pooled in the abstract. Authors declare no commercial or financial conflicts. Comparator: placebo. Front Med (Lausanne) 2024;11:1366062. Study type: review.
